These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20649011)

  • 21. Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
    Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wu ZH; Li Q
    Brain Res; 2010 Jan; 1310():189-99. PubMed ID: 19896932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [High-frequency electro-acupuncture stimulation modulates intracerebral γ-aminobutyric acid content in rat model of Parkinson's disease].
    Du J; Sun ZL; Jia J; Wang X; Wang XM
    Sheng Li Xue Bao; 2011 Aug; 63(4):305-10. PubMed ID: 21861048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Agrawal AK
    Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo detection of metabolic changes in the striatum of proteasomal inhibition-induced Parkinson's disease in rats using proton MR spectroscopy at 9.4 T.
    Yang Y; Qian J; Mei J; Zhong K; Niu C
    Int J Neurosci; 2020 Feb; 130(2):153-160. PubMed ID: 31516042
    [No Abstract]   [Full Text] [Related]  

  • 26. Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease.
    Armentero MT; Levandis G; Bramanti P; Nappi G; Blandini F
    Exp Neurol; 2008 Aug; 212(2):548-51. PubMed ID: 18508049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrastriatal infusion of liver growth factor stimulates dopamine terminal sprouting and partially restores motor function in 6-hydroxydopamine-lesioned rats.
    Reimers D; Herranz AS; Díaz-Gil JJ; Lobo MV; Paíno CL; Alonso R; Asensio MJ; Gonzalo-Gobernado R; Bazán E
    J Histochem Cytochem; 2006 Apr; 54(4):457-65. PubMed ID: 16344326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
    Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
    Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
    Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
    Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of striatum GABA concentrations and magnetic resonance spectroscopic imaging in Parkinson's disease monkeys.
    Huang L; Ren Y; Zeng Z; Ren H; Li S; He S; He F; Li X
    BMC Neurosci; 2019 Aug; 20(1):42. PubMed ID: 31395015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
    Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
    Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
    Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
    J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intracerebral transplantation of genetically modified cells for Parkinson's disease].
    Tang Z; Ying Q; Peng L
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):10-2. PubMed ID: 10374498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of electroacupuncture scalp point-through-point therapy on the expression of tyrosine hydroxylase and dopamine transporter mRNAs in substantia nigra of Parkinson's disease model rats].
    Wang S; Qi XJ; Han D
    Zhongguo Zhen Jiu; 2009 May; 29(5):391-4. PubMed ID: 19489498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats.
    Li Y; Huang XF; Deng C; Meyer B; Wu A; Yu Y; Ying W; Yang GY; Yenari MA; Wang Q
    Synapse; 2010 Mar; 64(3):224-30. PubMed ID: 19862688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protective effects of doxycycline upon dopaminergic neuron in LPS-induced rat model of Parkinson's disease].
    Wang PQ; Sun SG; Qiao X
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1346-50. PubMed ID: 19615192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease.
    Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wang T
    Brain Res; 2010 Apr; 1324():54-63. PubMed ID: 20149784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grafted neural stem cells migrate to substantia nigra and improve behavior in Parkinsonian rats.
    Zhu Qf; Ma J; Yu Ll; Yuan Cg
    Neurosci Lett; 2009 Oct; 462(3):213-8. PubMed ID: 19596403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
    van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
    Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.